NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-35 Cr | ₹-27 Cr | ₹-27 Cr | ₹-14 Cr | ₹-25 Cr |
What is the latest Cash Flow from Investing Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-35 Cr |
| Mar2024 | ₹-27 Cr |
| Mar2023 | ₹-27 Cr |
| Mar2022 | ₹-14 Cr |
| Mar2021 | ₹-25 Cr |
How is Cash Flow from Investing Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-35 Cr | Negative | |
| Mar2024 | ₹-27 Cr | Negative | |
| Mar2023 | ₹-27 Cr | Negative | |
| Mar2022 | ₹-14 Cr | Negative | |
| Mar2021 | ₹-25 Cr | - | |
Compare Cash Flow from Investing Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,391.7 Cr | 0.5% | 5.8% | 90.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 0.5% |
5.8% |
90.4% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses